Thermo Fisher Scientific Inc. (NYSE:TMO) shares hit a new 52-week high during trading on Tuesday . The stock traded as high as $159.13 and last traded at $158.73, with a volume of 788,991 shares changing hands. The stock had previously closed at $156.98.

TMO has been the subject of a number of research analyst reports. BTIG Research raised shares of Thermo Fisher Scientific from a “neutral” rating to a “buy” rating and set a $180.00 price objective for the company in a report on Friday, July 22nd. Zacks Investment Research cut shares of Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research report on Thursday, July 21st. Goldman Sachs Group Inc. reiterated a “buy” rating on shares of Thermo Fisher Scientific in a research report on Wednesday, July 6th. Leerink Swann reiterated a “buy” rating on shares of Thermo Fisher Scientific in a research report on Sunday, May 29th. Finally, Mizuho boosted their price objective on shares of Thermo Fisher Scientific from $166.00 to $170.00 and gave the company a “buy” rating in a research report on Friday, May 27th. Two research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average price target of $157.25.

The company’s 50-day moving average price is $151.54 and its 200-day moving average price is $142.90. The firm has a market cap of $62.00 billion and a price-to-earnings ratio of 31.71.

Thermo Fisher Scientific (NYSE:TMO) last announced its quarterly earnings results on Thursday, July 28th. The company reported $2.03 earnings per share for the quarter, beating the consensus estimate of $2.01 by $0.02. The firm had revenue of $4.54 billion for the quarter, compared to analyst estimates of $4.50 billion. The company’s revenue was up 6.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.84 EPS. On average, analysts expect that Thermo Fisher Scientific Inc. will post $8.13 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Monday, October 17th. Stockholders of record on Thursday, September 15th will be given a dividend of $0.15 per share. The ex-dividend date is Tuesday, September 13th. This represents a $0.60 annualized dividend and a dividend yield of 0.38%.

In other news, CAO Peter E. Hornstra sold 7,811 shares of the business’s stock in a transaction dated Monday, May 16th. The shares were sold at an average price of $150.00, for a total transaction of $1,171,650.00. Following the transaction, the chief accounting officer now owns 21,246 shares of the company’s stock, valued at approximately $3,186,900. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Jim P. Manzi sold 1,137 shares of the business’s stock in a transaction dated Friday, June 3rd. The shares were sold at an average price of $153.00, for a total transaction of $173,961.00. Following the transaction, the director now directly owns 38,733 shares in the company, valued at approximately $5,926,149. The disclosure for this sale can be found here.

Several hedge funds and institutional investors have recently made changes to their positions in the stock. Morgan Stanley boosted its position in shares of Thermo Fisher Scientific by 5.0% in the fourth quarter. Morgan Stanley now owns 6,030,180 shares of the company’s stock valued at $855,382,000 after buying an additional 286,391 shares during the last quarter. Principal Financial Group Inc. boosted its position in shares of Thermo Fisher Scientific by 2.4% in the fourth quarter. Principal Financial Group Inc. now owns 534,595 shares of the company’s stock valued at $75,832,000 after buying an additional 12,627 shares during the last quarter. UBS Oconnor LLC purchased a new position in shares of Thermo Fisher Scientific during the fourth quarter valued at $1,277,000. Gulf International Bank UK Ltd boosted its position in shares of Thermo Fisher Scientific by 2.4% in the fourth quarter. Gulf International Bank UK Ltd now owns 118,261 shares of the company’s stock valued at $16,775,000 after buying an additional 2,800 shares during the last quarter. Finally, Sawtooth Asset Management Inc. boosted its position in shares of Thermo Fisher Scientific by 9,139.1% in the fourth quarter. Sawtooth Asset Management Inc. now owns 11,826 shares of the company’s stock valued at $1,678,000 after buying an additional 11,698 shares during the last quarter.

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.